Future therapy for non-alcoholic fatty liver disease

被引：37

作者：

Issa, Danny ^{[1
]}

Patel, Vaishali ^{[1
]}

Sanyal, Arun J. ^{[1
]}

机构：

[1] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA

来源：

LIVER INTERNATIONAL | 2018年 / 38卷

关键词：

cirrhosis; fibrosis; nonalcoholic fatty liver disease; nonalcoholic fatty liver disease activity score; nonalcoholic steatohepatitis; ACTIVATED PROTEIN-KINASE; CORONARY-HEART-DISEASE; VITAMIN-E; NATURAL-HISTORY; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; WEIGHT-LOSS; THIAZOLIDINEDIONE USE; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS;

D O I：

10.1111/liv.13676

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease is a leading cause of chronic liver disease and can lead to cirrhosis, hepatocellular cancer and end stage liver disease. It is also associated with increased cardiovascular and cancer related morbidity and mortality. The pathogenesis of non-alcoholic fatty liver disease includes metabolic stress to the liver associated with insulin resistance with downstream cell stress from reactive oxygen species and unfolded protein response with activation of inflammatory and fibrotic pathways. There are currently no approved therapies for non-alcoholic fatty liver disease. This review summarizes ongoing efforts to establish the treatment of non-alcoholic steatohepatitis the progressive form of non-alcoholic fatty liver disease. Therapies are currently directed towards improving the metabolic status of the liver, cell stress, apoptosis, inflammation or fibrosis. Several agents are now in pivotal trials and it is expected that the first therapies will be approved in 2-3years.

引用

页码：56 / 63

页数：8

共 84 条

[61] Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening [J].

Ratziu, Vlad ;

Harrison, Stephen A. ;

Francque, Sven ;

Bedossa, Pierre ;

Lehert, Philippe ;

Serfaty, Lawrence ;

Romero-Gomez, Manuel ;

Boursier, Jerome ;

Abdelmalek, Manal ;

Caldwell, Steve ;

Drenth, Joost P. H. ;

Anstee, Quentin M. ;

Hum, Dean ;

Hanf, Remy ;

Roudot, Alice ;

Megnien, Sophie ;

Staels, Bart ;

Sanyal, Arun .

GASTROENTEROLOGY, 2016, 150 (05) :1147-+

[62] A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis [J].

Ratziu, Vlad ;

de Ledinghen, Victor ;

Oberti, Frederic ;

Mathurin, Philippe ;

Wartelle-Bladou, Claire ;

Renou, Christophe ;

Sogni, Philippe ;

Maynard, Marianne ;

Larrey, Dominique ;

Serfaty, Lawrence ;

Bonnefont-Rousselot, Dominique ;

Bastard, Jean-Philippe ;

Riviere, Marc ;

Spenard, Jean .

JOURNAL OF HEPATOLOGY, 2011, 54 (05) :1011-1019

[63] An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice [J].

Reilly, Shannon M. ;

Chiang, Shian-Huey ;

Decker, Stuart J. ;

Chang, Louise ;

Uhm, Maeran ;

Larsen, Martha J. ;

Rubin, John R. ;

Mowers, Jonathan ;

White, Nicole M. ;

Hochberg, Irit ;

Downes, Michael ;

Yu, Ruth T. ;

Liddle, Christopher ;

Evans, Ronald M. ;

Oh, Dayoung ;

Li, Pingping ;

Olefsky, Jerrold M. ;

Saltiel, Alan R. .

NATURE MEDICINE, 2013, 19 (03) :313-321

[64] The effect of thiazolidinediones on adiponectin serum level: a meta-analysis [J].

Riera-Guardia, N. ;

Rothenbacher, D. .

DIABETES OBESITY & METABOLISM, 2008, 10 (05) :367-375

[65] Management of NAFLD: a stage-based approach [J].

Rinella, Mary E. ;

Sanyal, Arun J. .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (04) :196-205

[66] The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease [J].

Safadi, Rifaat ;

Konikoff, Fred M. ;

Mahamid, Mahmud ;

Zelber-Sagi, Shira ;

Halpern, Maya ;

Gilat, Tuvia ;

Oren, Ran .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (12) :2085-U365

[67] No Significant Effects of Ethyl-Eicosapentanoic Acid on Histologic Features of Nonalcoholic Steatohepatitis in a Phase 2 Trial [J].

Sanyal, Arun J. ;

Abdelmalek, Manal F. ;

Suzuki, Ayako ;

Cummings, Oscar W. ;

Chojkier, Mario .

GASTROENTEROLOGY, 2014, 147 (02) :377-+

[68]

Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572

[69] Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. [J].

Sanyal, Arun J. ;

Chalasani, Naga ;

Kowdley, Kris V. ;

McCullough, Arthur ;

Diehl, Anna Mae ;

Bass, Nathan M. ;

Neuschwander-Tetri, Brent A. ;

Lavine, Joel E. ;

Tonascia, James ;

Unalp, Aynur ;

Van Natta, Mark ;

Clark, Jeanne ;

Brunt, Elizabeth M. ;

Kleiner, David E. ;

Hoofnagle, Jay H. ;

Robuck, Patricia R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18) :1675-1685

[70] Thiazolidinedione use and bone loss in older diabetic adults [J].

Schwartz, Ann V. ;

Sellmeyer, Deborah E. ;

Vittinghoff, Eric ;

Palermo, Lisa ;

Lecka-Czernik, Beata ;

Feingold, Kenneth R. ;

Strotmeyer, Elsa S. ;

Resnick, Helaine E. ;

Carbone, Laura ;

Beamer, Brock A. ;

Park, Seok Won ;

Lane, Nancy E. ;

Harris, Tamara B. ;

Cummings, Steven R. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (09) :3349-3354

← 1 2 3 4 5 6 7 8 9 →